• Skip to primary navigation
  • Skip to main content
  • Skip to footer
United Health Products Inc Logo

United Health Products, Inc.

Innovative health products for the management of complicated bleeds.

  • Home
  • About
    • Leadership
    • Code of Ethics
  • Products
  • Careers
  • Investors
  • News
    • Press Releases
  • Contact

News

United Health Products Provides Regulatory Application Update 

June 6, 2025

Mount Laurel, New Jersey – June 6, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA’s Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of […]

Filed Under: Press Releases

United Health Products Announces OTCQB Uplisting and FDA Update 

May 2, 2025

Mount Laurel, New Jersey – May 1, 2025 – United Health Products, Inc. (OTCQB: UEEC) is pleased to announce that it has been approved to have its common shares uplisted from the OTC “Pink” market to the OTCQB Venture Market (“OTCQB”). The successful uplisting is effective May 1, 2025 and the company’s common shares will continue […]

Filed Under: Press Releases

United Health Products Provides Update on FDA and OTC Markets Applications

March 28, 2025

Mount Laurel, New Jersey – March 28, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities.   As previously disclosed, the FDA requested that certain additional sterilization and biocompatibility tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a […]

Filed Under: Press Releases

United Health Products Provides Update on Capital Markets and Regulatory Processes

March 13, 2025

Mount Laurel, New Jersey – March 13, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities.   As previously disclosed, UHP has submitted an application to OTC Markets to have its common shares quoted on the OTCQB market, which the company believes will increase the […]

Filed Under: Press Releases

United Health Products Provides Update on FDA PMA Application Process

January 31, 2025

Mount Laurel, New Jersey – January 31, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities.   As previously disclosed, UHP submitted to the FDA an Investigational Device Exemption application (IDE) last November, the approval of which is a precondition to enroll patients in the […]

Filed Under: Press Releases

United Health Products Provides Update on Clinical Study Process

December 2, 2024

Mount Laurel, New Jersey – December 2, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study.   As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gauze product (formerly branded as HemoStyp) in response to the FDA’s request for additional clinical […]

Filed Under: Press Releases

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Footer

Our Locations

Corporate Headquarters
520 Fellowship Road, Suite #D-406
Mt. Laurel, NJ 08054

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Contact Us

General Contact
info@uhpcorp.com
475.755.1005

Follow Us

  • Email
  • YouTube
  • Legal
  • Privacy Policy

Copyright © 2025 · United Health Products, Inc. All Rights Reserved. Website by Cindy Leigh Media